TRICORT 40MGML INJECTION
Country: Малезија
Језик: Енглески
Извор: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
Карактеристике производа
(SPC)
17-03-2023
Неки документи за овај производ тренутно нису доступни, можете послати захтев нашој служби за кориснике и ми ћемо вас обавестити чим их будемо могли добити.
Пошаљите упит.
Пошаљите упит.
Активни састојак:
TRIAMCINOLONE ACETONIDE
Доступно од:
PAHANG PHARMACY SDN. BHD.
INN (Међународно име):
TRIAMCINOLONE ACETONIDE
Јединице у пакету:
1 Vials
Произведен од:
CADILA PHARM LTD
Карактеристике производа
BACK SIDE
Pheochromocytoma crisis, which may be fatal, has been reported after
administration of systemic corticosteroids. Corticosteroids
should only be administered to patients with suspected or identified
pheochromocytoma after an appropriate risk/benefit evaluation.
OXXXXXXX
1389, Trasad Road, Dholka-382225,
Dist: Ahmedabad, Gujarat State, India. DATE OF REVISION:
15th March 2023
CO-TREATMENT WITH CYP3A INHIBITORS,
including cobicistat-containing products, is expected to increase the
risk of systemic side-
effects. The combination should be avoided unless the benefit
outweighs the increased risk of systemic corticosteroid side-effects,
in
which case patients should be monitored for systemic corticosteroid
side-effects.
Size : 120 x 400 mm
Export : Malaysia
Pantone P Black C
DG-15/03/23-V06
DG-18/11/22-V05
DG-28/07/22-V04
DG-21/07/22-V03
SS-29/11/18-V02
HV-10/10/16-V01
Прочитајте комплетан документ
